In high grade brain tumors, Tregs suppress activation, proliferation and cytokine production of CD4+/CD8+ T cells via secreted cytokines such as TGF-B and IL-10 or via cell-to cell contact mediated by the constitutively expressed CTLA-4 and PD-L1 checkpoints [61]. This evidence concerns the gene CD4 and brain neoplasm.